Information Journal Paper
APA:
Copy. (2017). Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. ANTICANCER DRUGS, 28(7), 717-722. SID. https://sid.ir/paper/656221/en
Vancouver:
Copy. Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. ANTICANCER DRUGS[Internet]. 2017;28(7):717-722. Available from: https://sid.ir/paper/656221/en
IEEE:
Copy, “Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer,” ANTICANCER DRUGS, vol. 28, no. 7, pp. 717–722, 2017, [Online]. Available: https://sid.ir/paper/656221/en